title: Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage.
abstract: Apoptotic cell death is considered to play a key role in gentamicin-induced cochlear hair cell loss. Inhibitor of apoptosis proteins (IAPs) are important regulators of apoptosis that can prevent activation of effector caspases. This study was designed to investigate the possible involvement of X-linked inhibitor of apoptosis protein (XIAP) in hair cell death due to gentamicin. Basal turn organ of Corti explants from postnatal day (p) p3 or p4 rats were maintained in tissue culture and were exposed to 35 muM gentamicin for up to 48 h. Effects of specific XIAP inhibitors on gentamicin-induced hair cell loss and caspase-3 activation were examined. XIAP inhibitors increased gentamicin-induced hair cell loss but an inactive analog had no effect. Caspase-3 activation was primarily observed at 36 or 48 h in gentamicin-treated hair cells, whereas caspase-3 activation peaked at 24-36 h when explants were treated with gentamicin and an XIAP inhibitor. The inhibitors alone had no effect on hair cells. Finally, a caspase-3 inhibitor decreased caspase-3 activation and hair cell loss induced by gentamicin and an XIAP inhibitor, but caspase-8 and -9 inhibitors did not. The results indicate that XIAP normally acts to decrease caspase-3 activation and hair cell loss during gentamicin ototoxicity, as part of a protective response to potentially damaging stimuli.
authors.affiliation: Department of Surgery, Division Otolaryngology and Neurosciences, University of California, San Diego School of Medicine, 9500 Gilman Drive #0666, La Jolla, CA 92093, USA.
authors.forename: K
authors.initials: K
authors.lastname: Tabuchi
authors.forename: K
authors.initials: K
authors.lastname: Pak
authors.forename: E
authors.initials: E
authors.lastname: Chavez
authors.forename: A F
authors.initials: AF
authors.lastname: Ryan
mesh_terms: D000704:Analysis of Variance; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D053148:Caspase 3 / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology*; D006198:Hair Cells, Auditory / Q000187:drug effects*; D009925:Organ of Corti / Q000166:cytology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: C520470:1396-11 compound; D000814:Aniline Compounds; D005839:Gentamicins; D011500:Protein Synthesis Inhibitors; D051636:X-Linked Inhibitor of Apoptosis Protein; D053148:Caspase 3